National litigation boutique MoloLamken LLP is ‘incredibly effective’ and has extensive experience in patent disputes, standing out in particular for its ability to handle appellate IP matters before the Supreme Court and Federal Courts of Appeals. Seasoned appellate practitioner Jeffrey A. Lamken is based in Washington DC and has comprehensive experience representing clients in the pharma, telecoms and tech industries in patent appeals at the Federal Circuit. The group also includes the ‘energetic and experienced attorney’ Ben Quarmby in New York, who specializes in trial and appellate litigation related to patent, trademark, trade secret, and tech licensing disputes, and Washington DC-based patent litigator Michael Pattillo.
Legal 500 redaktioneller Kommentar
- Profil
Referenzen
Unabhängig vom Legal 500-Forschungsteam zusammengestellt.
‘The MoloLamken team is incredibly effective and responsive in the quickest possible manner.’
‘They are a small but experienced team of lawyers who handle the patent litigation and always ready to go to trial if necessary.’
‘Ben Quarmby is very available and leads his team very efficiently to achieve results in a streamlined process.'
'Jonathan Barbee is dedicated to his tasks and responsive. Rayiner Hashem is customer centric, very enjoyable to work with him as he perfectly understand the aim of his tasks.’
‘Mr. Ben Quarmby is an energetic and experienced attorney in this area. He is always responsive and tries to give us practical advice based on his through knoweledge of the patent law and coourt proceedings.’
Kernmandanten
- Duke University
- AbbVie Inc.
- Allergan Sales, LLC
- VLSI Technology LLC
- DivX, LLC
- Baxter International Inc.
- World Programming Limited
- Merck Sharp & Dohme, LLC
- The Regents of the University of California, the University of Vienna, and Emmanuelle Charpentier
- Nokia
Highlight-Mandate
- Represented Amgen Inc. in the U.S. Supreme Court in a case addressing the Patent Act’s “enablement” requirement.
- Represented Merck Sharp & Dohme, LLC in a case defending a decision by the Patent Trial and Appeal Board rejecting a challenge to the validity of Merck patents.
- Represented the inventors of the CRISPR-Cas9 system for editing genes in appealing a decision of the Patent Trial and Appeal Board that declined to award that invention to them.
Anwält*innen
Führende Partner*innen
Die stärksten Partner*innen ihres Praxisbereichs, die eine führende Rolle in signifikanten Mandaten einnehmen und weitreichende Anerkennung unter Wettbewerbern und Mandanten genießen.
Praxisleitung
Jeffrey Lamken; Ben Quarmby; Michael Pattillo
Weitere Kernanwält*innen
Rayiner Hashem; Jonathan Barbee